Tags : Tyme

Eagle Signs a Co-Promotion Agreement with Tyme for SM-88 to

Vartika Singh January 8, 2020

Shots: Tyme to receive $20M up front for 10M restricted shares of common stock at $2/share, up to $20M milestones based on meeting @1EPs as OS in TYME-88-Panc pivotal trial […]readmore

Tags : Tyme

Eagle Signs a Co-Promotion Agreement with Tyme for SM-88 to

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Tyme

Eagle Signs a Co-Promotion Agreement with Tyme for SM-88 to

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company